MediTox s.r.o.


Main activities

Preclinical research and development in the field of cardiovascular disorders, ophthalmic diseases, diabetes, vaccine development

Comprehensive preclinical and toxicological service for human and veterinary pharmaceuticals, biological drugs, medical devices (PHARMA), food additives and chemicals and chemical preparations (REACH)

Animal models of selected human diseases (cardiovascular, ophthalmic, diabetes, ophthalmic, …)

Animal breeding – accredited breeding facility (dogs and non-human primates)
Ref. No.: 38715/2015-MZE-17214

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.


MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.


The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with, flexibility and competitive pricing.



BIO KOREA, March 30 – April 01, 2016, Soul, Korea

BIO KOREA 2016



BIO Europe Spring 2016, April 04 – April 06, 2016, Stockholm, Sweden

BIO Europe Spring 2016



KIHE, May 11- May 13, 2016, Almaty, Kazakhstan

KIHE 2016



BIO International Convention, June 06 – June 09, 2016, San Francisco, CA, USA

BIO International Convention 2016


MediTox s.r.o.

MediTox s.r.o.

MediTox s.r.o.